Research Peptide for Erectile Dysfunction
Active Substance: Bremelanotide
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (10 mg/vial)
PT-141 is commonly known by its scientific name, Bremelanotide, and is recognized for its role in addressing certain sexual dysfunction issues and potential benefits in bodybuilding.
PT-141, crafted by Dragon Pharma, is a synthetic peptide presented in a 2 mL vial, with each dose containing 10 mg of the active substance Bremelanotide. It is specifically designed to target and enhance sexual function.
Each vial of PT-141 consists of a precisely measured 10 mg dosage of Bremelanotide. The formulation is engineered to ensure purity and potency, meeting the highest standards of quality.
While primarily recognized for its therapeutic use, PT-141 may have potential benefits in bodybuilding due to its influence on blood flow and vascular function, contributing to improved exercise performance.
PT-141 is primarily indicated for the treatment of sexual dysfunction in both men and women. It has shown efficacy in addressing issues such as erectile dysfunction and female sexual arousal disorder.
For men, the recommended dosage of PT-141 is typically 2 mg administered subcutaneously or intramuscularly. The timing of administration may vary, and it is advisable to follow the guidance of a healthcare professional.
In women, a dosage of 1.75 mg of PT-141, administered subcutaneously or intramuscularly, has shown effectiveness in addressing sexual arousal disorders. Women should consult with a healthcare provider for personalized guidance.
PT-141 has a relatively short active life, and its effects are typically observed within a few hours after administration. The duration of action may vary among individuals.
Common side effects of PT-141 may include nausea, flushing, and headaches. These effects are usually mild and temporary. Users should monitor their response and consult with a healthcare professional if side effects persist.
Individuals with a history of cardiovascular issues or hypersensitivity to PT-141 should exercise caution. Pregnant or breastfeeding women should avoid its use. Consultation with a healthcare professional is advised before initiating therapy.
While overdosage of PT-141 is rare, exceeding recommended doses may increase the risk of side effects. In case of suspected overdosage, medical attention should be sought promptly.
PT-141 is not typically used in bodybuilding stacks or cycles due to its specific therapeutic nature. It is recommended to follow a prescribed treatment plan under the supervision of a healthcare professional.
PT-141 is presented in a 2 mL vial, with each vial containing 10 mg of Bremelanotide. The packaging is designed to maintain the stability and integrity of the peptide until the expiration date. This product is manufactured by Dragon Pharma.
To preserve its stability, PT-141 should be stored in a cool, dry place, away from direct sunlight and extreme temperatures. Adhering to proper storage conditions ensures the longevity and effectiveness of the peptide until the end of its shelf life.
Human Peptide Hormone
Active Substance: Pentadecapeptide
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (2 mg/vial)
Form: Powder
Laboratory Tested: 2024-03-22
Water for Injection
Active Substance: Sterile Water
Manufacturer: Dragon Pharma
Unit: 10 mL Vial (0.9%/vial)
Human Peptide Hormone
Active Substance: CJC-1295 DAC
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/vial)
Peptide Hormone
Active Substance: Ipamorelin
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/vial)
Laboratory Tested: 2023-11-20
Melanotropin Peptide
Active Substance: Melanotan 2
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (10 mg/vial)
Laboratory Tested: 2023-11-20
Human Peptide Hormone
Active Substance: Selank
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (10 mg/vial)
Laboratory Tested: 2023-11-20
Human Peptide Hormone
Active Substance: Semaglutide
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/mL)
Form: Powder
Laboratory Tested: 2024-06-17
Human Peptide Hormone
Active Substance: Semax
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/vial)
Laboratory Tested: 2023-11-20
Growth Hormone-Releasing Hormone
Active Substance: Sermorelin
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/vial)
Peptide Hormone
Active Substance: Thymosin Beta-4
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/mL)
Form: Powder
Laboratory Tested: 2024-03-22
Human Peptide Hormone
Active Substance: Tesamorelin
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/vial)
Human Peptide Hormone
Active Substance: Tirzepatide
Manufacturer: Dragon Pharma
Unit: 2 mL Vial (5 mg/vial)
Form: Powder
Laboratory Tested: 2024-06-17